Profile
| Metric | Value |
|---|---|
| Full Name | CVS Health Corporation |
| Ticker | NYSE: CVS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Country | United States |
| IPO | |
| Indexes | |
| Website | cvshealth.com |
| Employees | 219,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $80.13 | |
| Price, 1D Change | +0.97% | |
| Market Cap | $102B | |
| TTM Dividend Yield | 3.32% | |
| PE Ratio | 209.44 | |
| Beta | 0.31 | |
| Revenue | $373B | |
| Revenue, 1Y Change | +4.02% | |
| EPS | $3.66 | |
| EPS, 1Y Change | -43.48% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.67 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $3.66 | |
| EPS Estimate | $6.65 | |
| EPS Est. Change | +82.02% | |
| Revenue | $372.69B | |
| Revenue Estimate | $400.10B | |
| Revenue Est. Change | +7.36% | |
| Current Price | $80.13 | |
| Price Target | - | $95.00 |
| Price Tgt. Change | - | +18.56% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.01 | $6.47 | -19.25% | |
| $5.20 | $3.66 | -29.72% | |
| $6.65 | N/A | +82.02% | |
| $7.17 | N/A | +96.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $329.89B | $358.27B | +8.60% | |
| $371.65B | $372.69B | +0.28% | |
| $400.10B | N/A | +7.36% | |
| $410.30B | N/A | +10.09% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +81.21% | |
| Price, 3Y | -14.01% | |
| Market Cap, 1Y | +82.56% | |
| Market Cap, 3Y | -16.04% | |
| Revenue, 1Y | +4.02% | |
| Revenue, 3Y | +27.66% | |
| EPS, 1Y | -43.48% | |
| EPS, 3Y | -38.57% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $80.13 | |
| SMA 200 | $70.92 | |
| SMA 200 vs Price | -11.49% | |
| SMA 50 | $78.80 | |
| SMA 50 vs Price | -1.66% | |
| Beta | 0.31 | |
| ATR | $1.50 | |
| 14-Day RSI | 56.76 | |
| 10-Day Volatility | 10.52% | |
| 1-Year Volatility | 31.56% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.67 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.32% | |
| Total Dividend | $2.66 | |
| Dividends Paid | $3.37B | |
| Payout Ratio | 73.55% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $372.69B | |
| EPS | $3.66 | |
| Gross Profit | $51.28B | |
| Gross Margin | 13.76% | |
| Operating Profit | $9.92B | |
| Operating Margin | -83.58% | |
| Net Income | $4.59B | |
| Net Margin | 1.23% | |
| EBITDA | $14.52B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.10 | |
| Current Ratio | 0.81 | |
| Quick Ratio | 0.60 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 2.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 209.44 | |
| PS Ratio | 0.26 | |
| PB Ratio | 1.39 | |
| EV/EBITDA | 10.03 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $75.56B | |
| Cash & Equivalents | $11.09B | |
| Total Assets | $260.82B | |
| Current Assets | $68.65B | |
| Total Liabilities | $185.09B | |
| Current Liabilities | $84.61B | |
| Total Debt | $82.92B | |
| Short Term Debt | $7.49B | |
| Accounts Payable | $55.12B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $368.08B | |
| Operating Expenses | $41.36B | |
| Cost Of Goods Sold | $321.41B | |
| SG&A | $0.00 | |
| D&A | $4.60B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.56B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $9.11B | |
| CFI | -$7.61B | |
| CFF | -$1.14B | |
| Capex | $2.78B | |
| Free Cash Flow | $6.33B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Bernstein | → | |
| UBS | → | |
| Truist Securities | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Mizuho | → | |
| Barclays | → | |
| Baird | → | |
| Bernstein | → |
Analyst sentiment
Institutional ownership
Screeners with CVS
Data Sources & References
- CVS Official Website www.cvshealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- CVS Profile on Yahoo Finance finance.yahoo.com/quote/CVS
- CVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cvs
FAQ
What is the ticker symbol for CVS Health Corporation?
The ticker symbol for CVS Health Corporation is NYSE:CVS
Does CVS Health Corporation pay dividends?
Yes, CVS Health Corporation pays dividends. The last payment was $0.67, with an ex-dividend date on October 23, 2025
What sector is CVS Health Corporation in?
CVS Health Corporation is in the Healthcare sector
What industry is CVS Health Corporation in?
CVS Health Corporation is in the Healthcare Plans industry
What country is CVS Health Corporation based in?
CVS Health Corporation is headquartered in United States
When did CVS Health Corporation go public?
CVS Health Corporation initial public offering (IPO) was on November 20, 1996
Is CVS Health Corporation in the S&P 500?
Yes, CVS Health Corporation is included in the S&P 500 index
Is CVS Health Corporation in the NASDAQ 100?
No, CVS Health Corporation is not included in the NASDAQ 100 index
Is CVS Health Corporation in the Dow Jones?
No, CVS Health Corporation is not included in the Dow Jones index
When was CVS Health Corporation last earnings report?
CVS Health Corporation's most recent earnings report was on October 29, 2025
When does CVS Health Corporation report earnings?
The next expected earnings date for CVS Health Corporation is February 11, 2026
